BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 20725786)

  • 1. Gastrointestinal stromal tumors (GISTs): an updated experience.
    Machairas A; Karamitopoulou E; Tsapralis D; Karatzas T; Machairas N; Misiakos EP
    Dig Dis Sci; 2010 Dec; 55(12):3315-27. PubMed ID: 20725786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Duodenal gastrointestinal stromal tumor: From clinicopathological features to surgical outcomes.
    Marano L; Boccardi V; Marrelli D; Roviello F
    Eur J Surg Oncol; 2015 Jul; 41(7):814-22. PubMed ID: 25956211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of KIT in the management of patients with gastrointestinal stromal tumors.
    Hornick JL; Fletcher CD
    Hum Pathol; 2007 May; 38(5):679-87. PubMed ID: 17437861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastrointestinal stromal tumors of the stomach.
    Bennett JJ; Rubino MS
    Surg Oncol Clin N Am; 2012 Jan; 21(1):21-33. PubMed ID: 22098829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Gastrointestinal stromal tumors. Actual diagnosis and treatment].
    Anton CR; Balan G
    Rev Med Chir Soc Med Nat Iasi; 2005; 109(2):223-9. PubMed ID: 16607775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on the biology and therapy of gastrointestinal stromal tumors.
    D'Amato G; Steinert DM; McAuliffe JC; Trent JC
    Cancer Control; 2005; 12(1):44-56. PubMed ID: 15668652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developments in targeted therapy of advanced gastrointestinal stromal tumors.
    Rutkowski P; Symonides M; Zdzienicki M; Siedlecki JA
    Recent Pat Anticancer Drug Discov; 2008 Jun; 3(2):88-99. PubMed ID: 18537751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastrointestinal stromal tumors in children and young adults: a clinicopathologic, molecular, and genomic study of 15 cases and review of the literature.
    Prakash S; Sarran L; Socci N; DeMatteo RP; Eisenstat J; Greco AM; Maki RG; Wexler LH; LaQuaglia MP; Besmer P; Antonescu CR
    J Pediatr Hematol Oncol; 2005 Apr; 27(4):179-87. PubMed ID: 15838387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imatinib treatment for gastrointestinal stromal tumour (GIST).
    Lopes LF; Bacchi CE
    J Cell Mol Med; 2010 Jan; 14(1-2):42-50. PubMed ID: 19968734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastrointestinal stromal tumors (GIST): a single center experience.
    Kostka R; Gürlich R; Koldová L
    Acta Chir Belg; 2012 Jan; 112(1):33-9. PubMed ID: 22442907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Etiology of and therapy for gastrointestinal stromal tumor].
    Shinomura Y
    Nihon Naika Gakkai Zasshi; 2006 Sep; 95(9):1939-45. PubMed ID: 17037339
    [No Abstract]   [Full Text] [Related]  

  • 12. Multidisciplinary treatment of gastrointestinal stromal tumors.
    Kingham TP; DeMatteo RP
    Surg Clin North Am; 2009 Feb; 89(1):217-33, x. PubMed ID: 19186237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imatinib mesylate: in the treatment of gastrointestinal stromal tumours.
    Croom KF; Perry CM
    Drugs; 2003; 63(5):513-22; discussion 523-4. PubMed ID: 12600228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in cell biology, diagnosis, and therapy of gastrointestinal stromal tumor (GIST).
    Logroño R; Jones DV; Faruqi S; Bhutani MS
    Cancer Biol Ther; 2004 Mar; 3(3):251-8. PubMed ID: 14726714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastrointestinal stromal tumors: A multidisciplinary challenge.
    Sanchez-Hidalgo JM; Duran-Martinez M; Molero-Payan R; Rufian-Peña S; Arjona-Sanchez A; Casado-Adam A; Cosano-Alvarez A; Briceño-Delgado J
    World J Gastroenterol; 2018 May; 24(18):1925-1941. PubMed ID: 29760538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrointestinal stromal tumors (GISTs): a pathology view point.
    Sornmayura P
    J Med Assoc Thai; 2009 Jan; 92(1):124-35. PubMed ID: 19260254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimizing surgical and imatinib therapy for the treatment of gastrointestinal stromal tumors.
    Sicklick JK; Lopez NE
    J Gastrointest Surg; 2013 Nov; 17(11):1997-2006. PubMed ID: 23775094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of resistance patterns and phenotypic changes in gastrointestinal stromal tumors following imatinib mesylate therapy.
    Bickenbach K; Wilcox R; Veerapong J; Kindler HL; Posner MC; Noffsinger A; Roggin KK
    J Gastrointest Surg; 2007 Jun; 11(6):758-66. PubMed ID: 17417711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular analysis of secondary kinase mutations in imatinib-resistant gastrointestinal stromal tumors.
    Lim KH; Huang MJ; Chen LT; Wang TE; Liu CL; Chang CS; Liu MC; Hsieh RK; Tzen CY
    Med Oncol; 2008; 25(2):207-13. PubMed ID: 18488160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastrointestinal stromal tumors: overview of pathologic features, molecular biology, and therapy with imatinib mesylate.
    Koh JS; Trent J; Chen L; El-Naggar A; Hunt K; Pollock R; Zhang W
    Histol Histopathol; 2004 Apr; 19(2):565-74. PubMed ID: 15024716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.